These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19352271)

  • 21. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Chun FK
    Eur Urol; 2008 Aug; 54(2):400-1. PubMed ID: 18456392
    [No Abstract]   [Full Text] [Related]  

  • 23. C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience.
    Giovacchini G; Fallanca F; Landoni C; Gianolli L; Picozzi P; Attuati L; Terreni M; Picchio M; Messa C; Fazio F
    Clin Nucl Med; 2009 Jan; 34(1):7-10. PubMed ID: 19092373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biodistribution of the radiolabeled kinds of choline in male patients, assessed by PET/CT.
    Calabria F; Schillaci O
    Nucl Med Commun; 2016 Mar; 37(3):329-30. PubMed ID: 26815635
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of carbon-11 choline PET/CT in the management of uterine carcinoma: initial experience.
    Sofue K; Tateishi U; Sawada M; Maeda T; Terauchi T; Kano D; Arai Y; Inoue T; Sugimura K
    Ann Nucl Med; 2009 May; 23(3):235-43. PubMed ID: 19333688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer imaging with fluorine-18-labeled choline derivatives.
    Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
    Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-choline PET/CT for initial staging of advanced prostate cancer.
    Gutman F; Aflalo-Hazan V; Kerrou K; Montravers F; Grahek D; Talbot JN
    AJR Am J Roentgenol; 2006 Dec; 187(6):W618-21. PubMed ID: 17114515
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of intracranial meningioma detected by ¹⁸F-choline PET/CT and examined by PET/MRI fusion imaging.
    Calabria F; Calabria E; Chiaravalloti A; Barbarisi M; Schillaci O
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):306-7. PubMed ID: 25017381
    [No Abstract]   [Full Text] [Related]  

  • 30. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions.
    Li X; Liu Q; Wang M; Jin X; Liu Q; Yao S; Liu S; Li J
    Clin Nucl Med; 2008 Oct; 33(10):671-6. PubMed ID: 18806565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Incidental Uptake of 18F-Choline in Paraganglioma.
    Castello A; Zuccotti G; Bonatto E; Florimonte L; Castellani M
    Clin Nucl Med; 2022 Feb; 47(2):e129-e130. PubMed ID: 34507329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA approves 11C-choline for PET in prostate cancer.
    J Nucl Med; 2012 Dec; 53(12):11N. PubMed ID: 23203247
    [No Abstract]   [Full Text] [Related]  

  • 34. Brown tumours due to secondary hyperparathyroidism detected by 11C-choline PET/CT.
    García JR; Alvarez Moro FJ; Bassa P; Soler M; Llinares E; Riera E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):209-10. PubMed ID: 26337465
    [No Abstract]   [Full Text] [Related]  

  • 35. PET for prostate cancer imaging: still a quandary or the ultimate solution?
    Kotzerke J; Gschwend JE; Neumaier B
    J Nucl Med; 2002 Feb; 43(2):200-2. PubMed ID: 11850484
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma membrane phospholipid labeling to estimate tumor burden and kinetics.
    Dingli D; Lowe VJ
    Cancer Biol Ther; 2008 May; 7(5):748-9. PubMed ID: 18379193
    [No Abstract]   [Full Text] [Related]  

  • 37. CT evaluation of sacral tumors with neural involvement.
    Ciappetta P; Di Lorenzo N; Delfini R
    J Neurosurg Sci; 1981; 25(2):89-94. PubMed ID: 7334422
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac paraganglioma originating from the right coronary artery.
    Klinkenberg TJ; van der Horst-Schrivers ANA; Bouma W; Mariani MA
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):803. PubMed ID: 28007876
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac paraganglioma.
    Hai Z; Guangrui S
    Eur Heart J; 2018 Jun; 39(23):2219. PubMed ID: 24944325
    [No Abstract]   [Full Text] [Related]  

  • 40. Image of the month--quiz case. Paraganglioma.
    Huan L; Jaffe BM; Kandil E
    Arch Surg; 2011 Aug; 146(8):985-6. PubMed ID: 21844443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.